References
- Bassan R, Bourquin J-P, DeAngelo DJ, et al. New approaches to the management of adult acute lymphoblastic leukemia. J Clin Oncol [Internet]. 2018;36:3504–3519. Available from: http://ascopubs.org/doi/10.1200/JCO.2017.77.3648
- Mitchell RJ, Kirkwood AA, Barretta E, et al. IKZF1 alterations are not associated with outcome in 498 adults with B-precursor ALL enrolled in the UKALL14 trial. Blood Adv [Internet]. 2021;5:3322–3332. Available from: https://ashpublications.org/bloodadvances/article/5/17/3322/476674/IKZF1-alterations-are-not-associated-with-outcome
- Ribera J-M, Morgades M, Ciudad J, et al. Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome–negative adult lymphoblastic leukemia. Blood [Internet]. 2021;137:1879–1894. Available from: https://ashpublications.org/blood/article/137/14/1879/474081/Chemotherapy-or-allogeneic-transplantation-in-high
- Gu Z, Churchman ML, Roberts KG, et al. PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia. Nat Genet [Internet]. 2019;51:296–307. Available from: http://www.nature.com/articles/s41588-018-0315-5
- Iacobucci I, Kimura S, Mullighan CG. Biologic and therapeutic implications of genomic alterations in acute lymphoblastic leukemia. J Clin Med [Internet]. 2021;10:3792. Available from: https://www.mdpi.com/2077-0383/10/17/3792
- Cario G, Leoni V, Conter V, et al. BCR-ABL1-like acute lymphoblastic leukemia in childhood and targeted therapy. Haematologica [Internet]. 2020;105:2200–2204. Available from: https://new.haematologica.org/article/view/9757
- Herold T, Gökbuget N, Herold T. Philadelphia-Like acute lymphoblastic leukemia in adults. Curr Oncol Rep. 2017: 1–6.
- Bajel A, George B, Mathews V, et al. Adult ALL: treatment outcome and prognostic factors in an Indian population using a modified German ALL (GMALL) protocol. Leukemia [Internet]. 2007;21:2230–2233. Available from: http://www.nature.com/doifinder/10.1038/sj.leu.2404785
- Jain N, Roberts KG, Jabbour E, et al. Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults. Blood [Internet]. 2017;129:572–581. Available from: https://ashpublications.org/blood/article/129/5/572/36151/Phlike-acute-lymphoblastic-leukemia-a-highrisk
- Silva WF, Silverio A, Duarte BKL, et al. Philadelphia-positive B-lymphoblastic leukemia in a middle-income country – A real-world multicenter cohort. Leuk Res [Internet]. 2021;110:106666. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0145212621001673
- Crespo-Solis E, Espinosa-Bautista K, Alvarado-Ibarra M, et al. Retrospective study of adults With acute lymphoid leukemia in Mexico city: first report of the working group for acute leukemia (GTLA). Clin Lymphoma Myeloma Leuk [Internet]. 2017;17:S252. Available from: https://linkinghub.elsevier.com/retrieve/pii/S2152265017310182
- Fernandes da Silva Junior W, Medina AB, Yamakawa PE, et al. Treating adult acute lymphoblastic leukemia in Brazil—Increased early mortality using a German multicenter acute lymphoblastic leukemia-based regimen. Clin Lymphoma Myeloma Leuk [Internet]. 2018;18:e255–e259. Available from: http://linkinghub.elsevier.com/retrieve/pii/S2152265018301538
- Swerdlow SH, Campo E, Harris NL, et al. , WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (Revised 4th edition). 4th ed Lyon: Lyon: IARC; 2017.
- Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform [Internet]. 2009;42:377–381. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1532046408001226
- van Dongen J, Macintyre E, Gabert J, et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Leukemia [Internet]. 1999;13:1901–1928. Available from: http://www.nature.com/articles/2401592
- Tanizawa RS da S, Kumeda CA, Azevedo Neto Rd, et al. Karyotypic and fluorescent in situ hybridization study of the centromere of chromosome 7 in secondary myeloid neoplasms. Rev Bras Hematol Hemoter [Internet]. 2011;33:425–431. Available from: http://www.rbhh.org/?doi=10.5581/1516-8484.20110117
- Moreira LBP, Queiróz RdP, Suazo VK, et al. Detection by a simple and cheaper methodology of Ik6 and Ik10 isoforms of the IKZF1 gene is highly associated with a poor prognosis in B-lineage paediatric acute lymphoblastic leukaemia. Br J Haematol [Internet]. 2019;187. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16172
- Chalandon Y, Thomas X, Hayette S, et al. Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia. Blood. 2015;125:3711–3719.
- Daver N, Thomas D, Ravandi F, et al. Final report of a phase II study of imatinib mesylate with hyper-CVAD for the front-line treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. Haematologica. 2015;100:653–661.
- Foa R, Vitale A, Vignetti M, et al. Dasatinib as first-line treatment for adult patients with Philadelphia chromosome – positive acute lymphoblastic leukemia. Blood. 2011;118:6521–6528.
- Diogenes E, Junior P, Pracchia LF, et al. Prognostic factors in adolescent and adult patients With acute lymphoblastic leukemia With Two protocols of chemotherapy : A cross-sectional study. Clin lymphoma. Myeloma Leuk [Internet]. Elsevier Inc; 2015;15:e7–14. Available from: http://doi.org/10.1016/j.clml.2014.07.006
- Hunault-Berger M, Leguay T, Thomas X, et al. A randomized study of pegylated liposomal doxorubicin versus continuous-infusion doxorubicin in elderly patients with acute lymphoblastic leukemia:The GRAALL-SA1 study. Haematologica. 2011;96:245–252.
- Kantarjian HM, O’Brien S, Smith TL, et al. Results of treatment With Hyper-CVAD, a dose-intensive regimen, in Adult Acute lymphocytic leukemia. J Clin Oncol [Internet]. 2000;18:547–547. Available from: http://ascopubs.org/doi/10.1200/JCO.2000.18.3.547
- Pfeifer H, Cazzaniga G, van der Velden VHJ, et al. Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1. Leukemia [Internet]. 2019;33:1910–1922. Available from: http://www.nature.com/articles/s41375-019-0413-0
- Coustan-Smith E, Mullighan CG, Onciu M, et al. Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia. Lancet Oncol. 2009;10:147–156.
- NCI Dictionary of Cancer Terms [Internet]. [cited 2020 Nov 17]. Available from: https://www.cancer.gov/publications/dictionaries/cancer-terms
- Pui C-H, Howard SC. Current management and challenges of malignant disease in the CNS in paediatric leukaemia. Lancet Oncol [Internet]. 2008;9:257–268. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1470204508700706
- Maloney KW, Devidas M, Wang C, et al. Outcome in Children With standard-risk B-cell acute lymphoblastic leukemia: Results of Children’s Oncology Group trial AALL0331. J Clin Oncol [Internet]. 2020;38:602–612. Available from: https://ascopubs.org/doi/10.1200/JCO.19.01086
- Scrucca L, Santucci A, Aversa F. Competing risk analysis using R: an easy guide for clinicians. Bone Marrow Transplant [Internet]. 2007;40:381–387. Available from: http://www.nature.com/articles/1705727
- Perez-Andreu V, Roberts KG, Harvey RC, et al. Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse. Nat Genet [Internet]. 2013;45:1494–1498. Available from: http://www.nature.com/articles/ng.2803
- Roberts KG, Li Y, Payne-Turner D, et al. Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. N Engl J Med [Internet]. 2014;371:1005–1015. Available from: http://www.nejm.org/doi/10.1056/NEJMoa1403088
- Abdel-Rahman ZH, Heckman MG, Anagnostou T, et al. Identification of adult Philadelphia-like acute lymphoblastic leukemia using a FISH-based algorithm distinguishes prognostic groups and outcomes. Blood Cancer J [Internet]. 2021;11:156. Available from: https://www.nature.com/articles/s41408-021-00538-9
- Moorman A V, Barretta E, Butler ER, et al. Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study. Leukemia [Internet]. 2021. Available from: https://www.nature.com/articles/s41375-021-01448-2
- Beldjord K, Chevret S, Asnafi V, et al. Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia. Blood [Internet]. 2014;123:3739–3749. Available from: https://ashpublications.org/blood/article/123/24/3739/32968/Oncogenetics-and-minimal-residual-disease-are
- Chiaretti S, Vitale A, Cazzaniga G, et al. Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohorts. Haematologica [Internet]; 2013(98):1702–1710. Available from: http://www.haematologica.org/cgi/doi/10.3324/haematol.2012.080432
- Pui C-H. Results of therapy for acute lymphoblastic leukemia in black and white children. JAMA [Internet]. 2003;290:2001. Available from: http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.290.15.2001
- Vaughan J, Bouwer N, Willem P, et al. The translocation t(1;19)(q23;p13) (TCF3/PBX1 fusion) is the most common recurrent genetic abnormality detected amongst patients with B-cell lymphoblastic leukaemia in johannesburg. South Africa. South African J Oncol [Internet]. 2021;5. Available from: https://www.sajo.org.za/index.php/sajo/article/view/179
- Mittelman SD, Kim J, Raca G, et al. Increased prevalence of CRLF2 rearrangements in obesity-associated acute lymphoblastic leukemia. Blood [Internet]. 2021;138:199–202. Available from: https://ashpublications.org/blood/article/138/2/199/475790/Increased-prevalence-of-CRLF2-rearrangements-in
- Stock W, Luger SM, Advani AS, et al. A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403. Blood [Internet]. 2019;133:1548–1559. Available from: http://www.bloodjournal.org/lookup/doi/10.1182/blood-2018-10-881961
- Greenwood M, Trahair T, Sutton R, et al. An MRD-stratified pediatric protocol is as deliverable in adolescents and young adults as children with ALL. Blood Adv [Internet]. 2021. Available from: https://ashpublications.org/bloodadvances/article/doi/10.1182/bloodadvances.2021005576/477382/An-MRD-stratified-pediatric-protocol-is-as
- Yilmaz M, Kantarjian HM, Toruner G, et al. Translocation t(1;19)(q23;p13) in adult acute lymphoblastic leukemia – a distinct subtype with favorable prognosis. Leuk Lymphoma [Internet]. 2021;62:224–228. Available from: https://www.tandfonline.com/doi/full/10.1080/10428194.2020.1824071
- Frisch A, Ofran Y. How i diagnose and manage Philadelphia chromosome-like acute lymphoblastic leukemia. Haematologica [Internet]. 2019;104:2135–2143. Available from: http://www.haematologica.org/lookup/doi/10.3324/haematol.2018.207506
- den Boer ML, Cario G, Moorman AV, et al. Outcomes of paediatric patients with B-cell acute lymphocytic leukaemia with ABL-class fusion in the pre-tyrosine-kinase inhibitor era: a multicentre, retrospective, cohort study. Lancet Haematol [Internet]. 2021;8:e55–e66. Available from: https://linkinghub.elsevier.com/retrieve/pii/S2352302620303537
- Moorman AV, Schwab C, Winterman E, et al. Adjuvant tyrosine kinase inhibitor therapy improves outcome for children and adolescents with acute lymphoblastic leukaemia who have an ABL-class fusion. Br J Haematol [Internet]. 2020;191:844–851. Available from: https://onlinelibrary.wiley.com/doi/10.1111/bjh.17093
- Tanasi I, Ba I, Sirvent N, et al. Efficacy of tyrosine kinase inhibitors in Ph-like acute lymphoblastic leukemia harboring ABL-class rearrangements. Blood [Internet]. 2019;134:1351–1355. Available from: https://ashpublications.org/blood/article/134/16/1351/374966/Efficacy-of-tyrosine-kinase-inhibitors-in-Phlike
- Almanza-Huante E, Espinosa-Bautista K, Rangel-Patiño J, et al. Comparison of Two pediatric-inspired regimens to Hyper-CVAD in Hispanic adolescents and young Adults With Acute lymphoblastic leukemia. Clin Lymphoma Myeloma Leuk [Internet]. 2021;21:55–62.e2. Available from: https://linkinghub.elsevier.com/retrieve/pii/S2152265020303797
- Gurgel LA, Oliveira Ds, Leitão JPV, et al. Overall survival in patients with acute lymphoblastic leukemia treated with CALGB 8811 protocol in low income country. J BONE MARROW Transplant Cell Ther [Internet]. 2021;2:95. Available from: https://www.jbmtct.com.br/seer/index.php/jbmtct/article/view/95